NCT00503360
- Conditions
- Eye Diseases, Ocular Hypertension
- Locations
-
- Novartis Investigative site, Sydney, Australia Sydney, Australia
Clinical trial condition
Ocular Hypertension
Explore clinical trials studying Ocular Hypertension. Study availability and eligibility vary by location and protocol.
533 public trials
32 recruiting studies
Ocular Hypertension trial results
NCT00372931
- Conditions
- Eye Diseases, Glaucoma, Glaucoma, Open-Angle, +2 more
- Locations
-
- San Antonio Site San Antonio, Texas, United States
NCT00140062
- Conditions
- Eye Diseases, Glaucoma, Glaucoma, Open-Angle, +1 more
- Locations
-
- Pfizer Investigational Site Ekenäs, Finland
- Pfizer Investigational Site Helsinki, Finland
- Pfizer Investigational Site Helsinki, Finland
- Pfizer Investigational Site Kuopio, Finland
NCT00652496
- Conditions
- Eye Diseases, Glaucoma, Ocular Hypertension
- Locations
-
- Wenatchee, Washington, United States
NCT00652106
- Conditions
- Eye Diseases, Glaucoma, Ocular Hypertension
- Locations
-
- El Paso, Texas, United States
NCT00651859
- Conditions
- Eye Diseases, Glaucoma, Ocular Hypertension
- Locations
-
- San Francisco, California, United States
NCT00652483
- Conditions
- Eye Diseases, Glaucoma, Ocular Hypertension
- Locations
-
- Atlanta, Georgia, United States
NCT00651612
- Conditions
- Eye Diseases, Glaucoma, Ocular Hypertension
- Locations
-
- Newport Beach, California, United States
Completed
Cause of Pigment Dispersion Syndrome
NCT00005919
- Conditions
- Eye Diseases, Glaucoma, Glaucoma-Related Pigment Dispersion Syndrome, +3 more
- Locations
-
- National Eye Institute (NEI) Bethesda, Maryland, United States
NCT00001161
- Conditions
- Aniridia, Axenfeld-Rieger syndrome, Congenital Abnormalities, +17 more
- Locations
-
- National Eye Institute (NEI) Bethesda, Maryland, United States